Format
Sort by
Items per page

Send to

Choose Destination

Links from PubChem BioAssay

Items: 17

1.

Side chain SAR of bicyclic beta-lactamase inhibitors (BLIs). 1. Discovery of a class C BLI for combination with imipinem.

Blizzard TA, Chen H, Kim S, Wu J, Young K, Park YW, Ogawa A, Raghoobar S, Painter RE, Hairston N, Lee SH, Misura A, Felcetto T, Fitzgerald P, Sharma N, Lu J, Ha S, Hickey E, Hermes J, Hammond ML.

Bioorg Med Chem Lett. 2010 Feb 1;20(3):918-21. doi: 10.1016/j.bmcl.2009.12.069. Epub 2009 Dec 23.

PMID:
20044254
2.

Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries.

Minond D, Saldanha SA, Subramaniam P, Spaargaren M, Spicer T, Fotsing JR, Weide T, Fokin VV, Sharpless KB, Galleni M, Bebrone C, Lassaux P, Hodder P.

Bioorg Med Chem. 2009 Jul 15;17(14):5027-37. doi: 10.1016/j.bmc.2009.05.070. Epub 2009 Jun 22.

3.

Drug delivery approaches to overcome bacterial resistance to beta-lactam antibiotics.

Abeylath SC, Turos E.

Expert Opin Drug Deliv. 2008 Sep;5(9):931-49. doi: 10.1517/17425247.5.9.931 . Review.

PMID:
18754746
4.

Metallo-beta-lactamases of Pseudomonas aeruginosa--a novel mechanism resistance to beta-lactam antibiotics.

Sacha P, Wieczorek P, Hauschild T, Zórawski M, Olszańska D, Tryniszewska E.

Folia Histochem Cytobiol. 2008;46(2):137-42. doi: 10.2478/v10042-008-0020-9. Review.

6.

An update on newer beta-lactamases.

Gupta V.

Indian J Med Res. 2007 Nov;126(5):417-27. Review.

PMID:
18160745
7.

Imipenem-resistant Pseudomonas aeruginosa producing IMP-1 metallo-beta-lactamases and lacking the outer-membrane protein OprD.

Wang CX, Mi ZH.

J Med Microbiol. 2006 Mar;55(Pt 3):353-4. No abstract available.

PMID:
16476803
8.

Miniaturization of absorbance assays using the fluorescent properties of white microplates.

Zuck P, O'Donnell GT, Cassaday J, Chase P, Hodder P, Strulovici B, Ferrer M.

Anal Biochem. 2005 Jul 15;342(2):254-9.

PMID:
15949786
9.

Metallo-beta-lactamases: the quiet before the storm?

Walsh TR, Toleman MA, Poirel L, Nordmann P.

Clin Microbiol Rev. 2005 Apr;18(2):306-25. Review.

10.

Comparative study of the inhibition of metallo-beta-lactamases (IMP-1 and VIM-2) by thiol compounds that contain a hydrophobic group.

Jin W, Arakawa Y, Yasuzawa H, Taki T, Hashiguchi R, Mitsutani K, Shoga A, Yamaguchi Y, Kurosaki H, Shibata N, Ohta M, Goto M.

Biol Pharm Bull. 2004 Jun;27(6):851-6.

11.

Bacterial wall as target for attack: past, present, and future research.

Koch AL.

Clin Microbiol Rev. 2003 Oct;16(4):673-87. Review.

12.

Comparison of methods of interpretation of checkerboard synergy testing.

Bonapace CR, Bosso JA, Friedrich LV, White RL.

Diagn Microbiol Infect Dis. 2002 Dec;44(4):363-6.

PMID:
12543542
13.
14.

Metallo-beta-lactamase: structure and mechanism.

Wang Z, Fast W, Valentine AM, Benkovic SJ.

Curr Opin Chem Biol. 1999 Oct;3(5):614-22. Review.

PMID:
10508665
15.

Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate.

Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, Rossolini GM.

Antimicrob Agents Chemother. 1999 Jul;43(7):1584-90.

16.

Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP.

Hirakata Y, Izumikawa K, Yamaguchi T, Takemura H, Tanaka H, Yoshida R, Matsuda J, Nakano M, Tomono K, Maesaki S, Kaku M, Yamada Y, Kamihira S, Kohno S.

Antimicrob Agents Chemother. 1998 Aug;42(8):2006-11.

17.

Supplemental Content

Support Center